Company Overview of Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc., together with its subsidiaries, develops proprietary therapies for the treatment of cancer. It also evaluates new therapeutic agents and/or related technologies that involve the examination of individual molecules, classes of compounds, or platform technologies. The company provides therapeutic candidate programs, including TPI 287 IV and TIP 287 oral formulations for prostate, non-small cell lung, and other cancers. The company was founded in 1991 and is based in Boulder, Colorado.
4840 Pearl East Circle
Suite 300 W
Boulder, CO 80301-2408
Founded in 1991
Key Executives for Tapestry Pharmaceuticals, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Tapestry Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.